Insights

The Value of an Integrated Medical Writing Partner 

As development programs progress, the volume and complexity of scientific documentation increase significantly. From investigator’s brochures (IBs), clinical study protocols, and briefing packages to…

Meet Morula Health at ESMO 2026

Morula Health will attend ESMO 2026 in Madrid. Connect with our team to discuss regulatory and medical writing support and book a meeting.

Investigator’s brochure (IB) guide:  How to write and update an IB for clinical trials aligned with ICH E6(R3)

Developing and maintaining an Investigator’s Brochure requires the effective integration of evolving nonclinical, clinical, and manufacturing information. This guide explores the key considerations, processes, and…

Looking Ahead to ESMO 2026: Supporting the Next Generation of Oncology Innovation

As ESMO 2026 approaches, oncology remains one of the most dynamic areas of drug development. From precision medicine and antibody-drug conjugates to radiopharmaceuticals and AI-driven…

From China to Global Markets: Preparing Biotech Assets for FDA and EMA

Explore the growing role of China-originated biotech assets and why early documentation strategy is key to global regulatory success.

Key Insights from the EMWA 2026 Conference in Barcelona

Get the latest key insights from the EMWA 2026 event, where leaders shared their thoughts on the future of medical writing in Barcelona.

Your IND Application Is Only as Strong as the Documents Behind It

A well-prepared IND is a signal of scientific credibility to future partners, investors, and licensing counterparts.

Morula Health at EMWA 2026

Meet Morula Health at EMWA 2026 in Barcelona. Connect with Phil Burridge to discuss regulatory, clinical, and medical writing expertise.

Morula Health Announces Charitable Donation to MPS Society

Morula Health has announced a charitable donation to the Society for Mucopolysaccharide Diseases (MPS).